M.V. Mateos

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

Anna Sureda, M. Constans, A Iriondo et al. · Annals of Oncology · 2005 · 220 citations · Full text

Medicine, Hematology, Oncology +17

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study

Juan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López et al. · Haematologica · 2010 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Genomic analysis of high-risk smoldering multiple myeloma

Lucía López‐Corral, M.V. Mateos, Luís A. Corchete et al. · Haematologica · 2012 · 49 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome

M. Constans, Anna Sureda, María José Terol et al. · Annals of Oncology · 2003 · 46 citations

Medicine, Hematology, Surgery +14

Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.

Marcos González, Ricardo López‐Pérez, Ramón García‐Sánz et al. · PubMed · 1999 · 42 citations

Medicine, Hematology, Molecular Biology +17